The intraosseous infusion devices market was valued at USD 5.1 billion in 2025, is projected to reach USD 11.2 billion by 2036 and is forecast to register a 7.6% CAGR between 2026 and 2036, creating an incremental opportunity of USD 5.8 billion. In 2026, automatic systems hold 51.0% of product type demand.